Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 3 48-3, 2003, Pages

  Bataller, Ramón ^a   Gäbele, Erwin ^a   Schoonhoven, Robert ^a   Morris, Terry ^a   Lehnert, Mark ^b   Yang, Liu ^a   Brenner, David A ^a   Rippe, Richard A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cytokines; Hepatic inflammation; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; COLLAGEN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CELL ACTIVATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOLOGY; INFLAMMATION; LIVER INJURY; MALE; NONHUMAN; OSMOTIC PUMP; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION; RAT; STELLATE CELL; THROMBOSIS; UPREGULATION;

EID: 0042009848     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00037.2003     Document Type: Article

References (44)

1. Abrahamsen CT, Pullen MA, Schnackenberg CG, Grygielko ET, Edwards RM, Laping NJ, and Brooks DP. Effects of angiotensins II and IV on blood pressure, renal function, and PAI-1 expression in the heart and kidney of the rat. Pharmacology 66: 26-30, 2002.
2. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, and Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118: 1149-1156, 2000.
3. Bataller R, Gines P, Sancho-Bru P, Lora J, Sole M, Nicolas J, Jimenez W, Arroyo V, and Rodes J. Human activated hepatic stellate cells express the renin-angiotensin system and secrete angiotensin II. Gastroenterology. In press.
4. Bataller R, Schwabe R, Qian T, Lemasters J, and Brenner D. Angiotensin II stimulates the secretion of proinflammatory cytokines in human hepatic stellate cells via MAPk activation induced by oxidative stress (Abstract). Hepatology 34: 402A, 2001.
5. Boya P, Larrea E, Sola I, Majano PL, Jimenez C, Civeira MP, and Prieto J. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression. Hepatology 34: 1041-1048, 2001.
6. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, Hannun Y, Lemasters JJ, Thuman RG, and Brenner DA. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25: 1128-1135, 1997.
7. Brasier AR, Recinos A 3rd, and Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22: 1257-1266, 2002.
8. Burt AD and MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 39: 63-67, 1986.
9. Cohn JN and Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345: 1667-1675, 2001.
10. Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, Vuillemin E, Gallois Y, Douay O, Chappard D, and Cales P. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol 37: 773-780, 2002.
11. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, and Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension 19: 464-474, 1992.
12. Kim KY, Rhim T, Choi I, and Kim SS. N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J Biol Chem 276: 40591-40598, 2001.
13. Lang A, Schoonhoven R, Tuvia S, Brenner DA, and Rippe RA. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 33: 49-58, 2000.
14. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, and Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860, 2001.
15. Lombardi DM, Viswanathan M, Vio CP, Saavedra JM, Schwartz SM, and Johnson RJ. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron 87: 66-74, 2001.
16. Mann DA and Smart DE. Transcriptional regulation of hepatic stellate cell activation. Gut 50: 891-896, 2002.
17. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, Efsen E, Laffi G, and Gentilini P. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 30: 951-958, 1999.
18. Marshall RP, McAnulty RJ, and Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161: 1999-2004, 2000.
19. Nakazawa Y, Jonsson JR, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, and Clouston AD. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. Hepatology 32: 1240-1247, 2000.
20. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, and Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37: 1043-1055, 2003.
21. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, and Angus PW. Up-regulation of components of the reninangiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-1676, 2002.
22. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, and Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 35: 376-385, 2001.
23. Parola M and Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 35: 297-306, 2001.
24. Pogliaghi G, Tacchini L, Anzon E, Radice L, and Bernelli-Zazzera A. Heat shock activation of NFκB in rat liver is mediated by interleukin-1. FEBS Lett 372: 181-184, 1995.
25. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, and Jonsson JR. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31: 828-833, 2000.
26. Ramalho LN, Ramalho FS, Zucoloto S, Castro-e-Silva Junior O, Correa FM, Elias J Jr, and Magalhaes JF. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis. Hepatogastroenterology 49: 1499-1502, 2002.
27. Reeves HL and Friedman SL. Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci 7: d808-d826, 2002.
28. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, and Egido J. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38: 1382-1387, 2001.
29. Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, and Egido J. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 16, Suppl 1: 27-33, 2001.
30. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, and Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10: 321-329, 2001.
31. Schiffrin EL. Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med 113: 409-418, 2002.
32. Schnabl B, Bradham CA, Bennett BL, Manning AM, Stefanovic B, and Brenner DA. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology 34: 953-963, 2001.
33. Schneider AW, Kalk JF, and Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29: 334-339, 1999.
34. Schwabe RF, Schnabl B, Kweon YO, and Brenner DA. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 166: 6812-6819, 2001.
35. Sigusch HH, Campbell SE, and Weber KT. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. Cardiovasc Res 31: 546-554, 1996.
36. Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346: 1999-2001, 2002.
37. Stefanovic B and Brenner DA. 5′ stem-loop of collagen alpha 1(I) mRNA inhibits translation in vitro but is required for triple helical collagen synthesis in vivo. J Biol Chem 278: 927-933, 2003.
38. Strawn WB and Ferrario CM. Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol 13: 505-512, 2002.
39. Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, and Sakuta S. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology 36: 1022, 2002.
40. Uehara T, Bennet B, Sakata S, Satoh Y, and Brenner D. JNK inhibitors protect from hepatic ischemia/reperfusion injury (Abstract). Hepatology 34: 348A, 2001.
41. Uesugi T, Froh M, Arteel GE, Bradford BU, Gabele E, Wheeler MD, and Thurman RG. Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 34: 1149-1157, 2001.
42. Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR, Huang X, Cheng JL, and Xu QF. The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCl(4). World J Gastroenterol 6: 824-828, 2000.
43. Wiener J, Lombardi DM, Su JE, and Schwartz SM. Immunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin-II infusion. J Vasc Res 33: 195-208, 1996.
44. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Imazu H, Yanase K, Kuriyama S, and Fukui H. Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol 37: 22-30, 2002.